Literature DB >> 27928401

Idiopathic Acquired Temporal Wedge Visual Field Defects.

Michael J Gilhooley1, Clare L Fraser2, Sui Wong1, Simon J Hickman3, Gordon T Plant4.   

Abstract

Our aim is to report 13 unusual cases of acquired, temporal sectoral scotomas. Such stationary "wedge" field defects have been reported previously in cases of presumed congenital nasal hypoplasia of the optic disc and as a complication of vitreoretinal surgery. To our knowledge, the literature provides no reports of similar defects occurring spontaneously. This is a descriptive clinical case series of 13 patients presenting with sub-acute monocular temporal visual field loss. All were clinically assessed and investigated with Goldmann perimetry, automated Humphrey visual fields, retinal optical coherence tomography, orbital ultrasound, and standard and multi-focal electroretinography. Cases were followed with serial perimetry for a mean of 3.9 years (range: 6 months to 10 years). Goldmann and Humphrey perimetry both demonstrated "wedge"-shaped defects extending temporally from an apex contiguous with, or lateral to, the blind spot. There was no evidence of optic disc drusen, glaucoma, disc hypoplasia, or focal retinitis. Sectoral optic disc swelling was not present in any patient at presentation. In all cases, the visual field defect remained stable. One patient developed a similar defect in the fellow eye after an interval of 5 years. Here we describe 13 cases of acquired, stationary temporal wedge scotomas, novel in the literature. Although the aetiology is uncertain, we propose damage to the nasal rim of the optic disc as a likely mechanism.

Entities:  

Keywords:  Temporal; defects; field; scotomas; wedge

Year:  2016        PMID: 27928401      PMCID: PMC5122908          DOI: 10.1080/01658107.2016.1195413

Source DB:  PubMed          Journal:  Neuroophthalmology        ISSN: 0165-8107


  20 in total

1.  Acute zonal occult outer retinopathy: towards a set of diagnostic criteria.

Authors:  P J Francis; A Marinescu; F W Fitzke; A C Bird; G E Holder
Journal:  Br J Ophthalmol       Date:  2005-01       Impact factor: 4.638

2.  Vitreopapillary traction confirmed by optical coherence tomography.

Authors:  Thomas R Hedges; Nancy L Flattem; Arlene Bagga
Journal:  Arch Ophthalmol       Date:  2006-02

3.  Nonarteritic anterior ischemic optic neuropathy (NAION): a misnomer. Rearranging pieces of a puzzle to reveal a nonischemic papillopathy caused by vitreous separation.

Authors:  Cameron F Parsa; William F Hoyt
Journal:  Ophthalmology       Date:  2015-03       Impact factor: 12.079

4.  Peripheral visual field defects after macular hole surgery: a complication with decreasing incidence.

Authors:  C A Gass; C Haritoglou; E M Messmer; M Schaumberger; A Kampik
Journal:  Br J Ophthalmol       Date:  2001-05       Impact factor: 4.638

5.  Temporal visual field defects associated with nasal hypoplasia of the optic disc.

Authors:  T A Buchanan; W F Hoyt
Journal:  Br J Ophthalmol       Date:  1981-09       Impact factor: 4.638

6.  Gaze-evoked amaurosis from vitreopapillary traction.

Authors:  Barrett Katz; William F Hoyt
Journal:  Am J Ophthalmol       Date:  2005-04       Impact factor: 5.258

7.  [Causes of visual field defects after vitrectomy].

Authors:  H Takenaka; T Maeno; T Mano; H Mitsuda
Journal:  Nippon Ganka Gakkai Zasshi       Date:  1999-05

8.  Clinical distinction between nasal optic disc hypoplasia (NOH) and glaucoma with NOH-like temporal visual field defects.

Authors:  Hiroshi Ohguro; Ikuyo Ohguro; Midori Tsuruta; Maki Katai; Sachie Tanaka
Journal:  Clin Ophthalmol       Date:  2010-06-24

9.  Visual function and patient satisfaction after macular hole surgery.

Authors:  I A Pearce; M Branley; C Groenewald; J McGalliard; D Wong
Journal:  Eye (Lond)       Date:  1998       Impact factor: 3.775

10.  Photopsia and a temporal visual field defect.

Authors:  Marcela Marsiglia; Jeffery G Odel; Danielle S Rudich; Stephen H Tsang; Gordon T Plant
Journal:  Surv Ophthalmol       Date:  2015-11-19       Impact factor: 6.048

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.